On August 29, 2025, Procter & Gamble reported Q4 2025 earnings that exceeded analyst estimates, with adjusted EPS of US$1.48 and revenues of US$20.89 billion, and announced strong forward guidance for fiscal 2026.
P&G’s announcement highlights management’s confidence in delivering ongoing organic sales and free cash flow growth, despite the challenging business backdrop.
We'll examine how Procter & Gamble's robust earnings report and upbeat outlook could shape its investment narrative for...
Crown Castle recently announced plans to divest its fiber division by mid-2026 and appointed a new CEO to lead the company’s next chapter.
This move signals a shift toward focusing on core tower infrastructure, which many analysts believe could enhance operational efficiency and shareholder value.
We’ll explore how the intention to sell the fiber business could shape Crown Castle’s investment case moving forward.
Outshine the giants: these 25 early-stage AI stocks could fund your...
Paycom Software (PAYC) just made some major moves in its executive team, announcing new leadership roles focused on technology and automation. Shane Hadlock is taking on a dual role as both chief client officer and chief technology officer, while Rachael Gannon has been promoted to chief automation officer, effective August 18, 2025. The company also named Brad Smith as senior technical strategist. These changes indicate that Paycom is emphasizing both innovation and client experience,...
In August 2025, General Mills announced a US$54 million investment to expand its James Ford Bell Technical Center, adding a new 35,000-square-foot pilot plant facility to strengthen innovation and product development capabilities.
This expansion highlights the company's focus on accelerating research and development to support long-term growth across its business units.
We'll examine how the technical center expansion may shape General Mills' investment narrative and future prospects for...
Johnson & Johnson recently announced that 10-year clinical trial results presented at the European Society of Cardiology Congress and published in the New England Journal of Medicine found that routine use of the Impella CP heart pump in patients with heart attacks complicated by cardiogenic shock led to a significant and increasing absolute reduction in mortality compared to standard care.
The findings position Impella CP as the first mechanical circulatory support device proven in a...
CVS Health recently announced it will not offer the 2025–2026 COVID-19 vaccine in 16 states and Washington, D.C., due to evolving regulatory requirements that limit vaccines to those endorsed by the Advisory Committee on Immunization Practices (ACIP).
This restriction may significantly reduce vaccine access ahead of the upcoming respiratory virus season, raising operational and business challenges for pharmacy providers like CVS.
We'll examine how CVS Health's decision to stop administering...
Prudential Financial (PRU) has made some moves that could have investors pausing to reassess their outlook. The company rolled out enhancements to its EssentialTerm Suite, aiming to make term life insurance more flexible, easier to convert, and simpler to buy, especially for customers with meaningful coverage needs. In addition, Prudential has tapped capital markets with two new senior unsecured note offerings, adding fixed-income firepower to its balance sheet. These steps, focused on both...
